Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · IEX Real-Time Price · USD
2.250
+0.010 (0.45%)
At close: Jul 26, 2024, 4:00 PM
2.263
+0.013 (0.58%)
After-hours: Jul 26, 2024, 5:00 PM EDT

Cardiol Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2017
Market Capitalization
15554321127291
Upgrade
Market Cap Growth
291.48%67.34%-71.06%56.56%-21.55%23.29%
Upgrade
Enterprise Value
12524-16905984
Upgrade
Last Close Price
1.810.840.511.852.183.54
Upgrade
PE Ratio
--1.93-1.03-2.53-3.15-6.67
Upgrade
PS Ratio
---1424.94--
Upgrade
PB Ratio
7.641.920.621.475.406.23
Upgrade
P/FCF Ratio
-5.52-2.15-1.19-4.77-7.82-7.74
Upgrade
P/OCF Ratio
-5.52-2.16-1.19-4.77-7.85-8.03
Upgrade
EV/Sales Ratio
---1138.75--
Upgrade
EV/EBITDA Ratio
-3.06-0.800.39-2.33-2.88-7.12
Upgrade
EV/EBIT Ratio
-3.04-0.800.38-2.32-2.84-7.04
Upgrade
EV/FCF Ratio
-4.17-0.940.58-3.81-6.42-7.09
Upgrade
Debt / Equity Ratio
0.010.010.000.000.010.01
Upgrade
Debt / FCF Ratio
-0.01-0.010.000.00-0.02-0.02
Upgrade
Asset Turnover
---0.00--
Upgrade
Quick Ratio
2.654.246.117.295.6611.42
Upgrade
Current Ratio
2.814.366.277.535.9420.81
Upgrade
Return on Equity (ROE)
-92.11%-69.93%-48.16%-70.69%-147.74%-74.08%
Upgrade
Return on Assets (ROA)
-45.35%-37.71%-34.47%-46.58%-82.38%-36.99%
Upgrade
Return on Capital (ROIC)
-57.72%-46.14%-40.17%-53.83%-91.42%-39.75%
Upgrade
Earnings Yield
-19.73%-51.76%-95.24%-28.19%-28.79%-14.98%
Upgrade
FCF Yield
-14.48%-46.45%-84.04%-20.99%-12.79%-12.92%
Upgrade
Buyback Yield / Dilution
-4.94%-3.13%-44.61%-44.77%-15.63%-67.97%
Upgrade
Total Shareholder Return
-4.94%-3.13%-44.61%-44.77%-15.63%-67.97%
Upgrade
Source: S&P Capital IQ. Standard template.